PIRS - Pieris Pharmaceuticals EPS in-line misses on revenue March, 30 2021 07:07 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals (PIRS): FY GAAP EPS of -$0.68 in-line.Revenue of $29.32M (-36.6% Y/Y) misses by $0.85M.Shares +6% PM.Press Release For further details see: Pieris Pharmaceuticals EPS in-line, misses on revenue